Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia

Abstract

Treatment with eltrombopag was associated with multilineage clinical responses in some patients with refractory severe aplastic anemia. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov number, NCT00922883.).